Nautilus Biotechnology NAUT
NASDAQ NAUT
$1.57 +0.15 (+10.21%)
As of: Oct 1, 2026 · 3:59 PM EDT

Nautilus Biotechnology (NAUT) Income from Continuing Operations (2020 - 2026)

Updated

Nautilus Biotechnology (NAUT) reported Income from Continuing Operations of -$15.76 million for Q2 2026, compared with -$17.1 million a year earlier.

Analysis

Nautilus Biotechnology (NAUT) Income from Continuing Operations (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Nautilus Biotechnology's Income from Continuing Operations came in at -$34.83 million; for FY2020, it was -$576,035.

  • The Q2 2026 figure ranks as the highest quarterly Income from Continuing Operations since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 1.76 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 928.00 Mn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 870.00 Mn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 823.20 Mn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 1.48 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -220.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 905.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 241.40 Mn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 451.00 Mn
10 Nautilus Biotechnology 180.66 Mn 180.66 Mn 175,000.00 -15.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.76 Mn
Jun 30, 2025 -17.10 Mn
Mar 31, 2021 -1.78 Mn
Sep 30, 2020 -174,671.00
API Access

Nautilus Biotechnology Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=NAUT&period=max&api_key=YOUR_API_KEY